MorphoSys AG is a biopharmaceutical company founded in 1992. The company is headquartered near Munich, Germany and has a wholly owned subsidiary, MorphoSys US Inc., in Boston MA in the US.
Company profile
Ticker
MOR, MPSYF
Exchange
Website
CEO
Simon Moroney
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
MOR stock data
Latest filings (excl ownership)
SC TO-T/A
Third party tender offer statement (amended)
18 Apr 24
6-K
Current report (foreign)
18 Apr 24
SC 14D9/A
Tender offer solicitation (amended)
17 Apr 24
SC TO-T/A
Third party tender offer statement (amended)
17 Apr 24
SC TO-T/A
Third party tender offer statement (amended)
16 Apr 24
6-K
Current report (foreign)
16 Apr 24
SC TO-T/A
Third party tender offer statement (amended)
15 Apr 24
6-K
Current report (foreign)
12 Apr 24
SC 14D9
Tender offer solicitation
11 Apr 24
SC TO-T
Third party tender offer statement
11 Apr 24
Latest ownership filings
SC 13D
NOVARTIS AG
18 Apr 24
SC 13G
GOLDMAN SACHS GROUP INC
11 Mar 24
SC 13G/A
Kynam Capital Management, LP
8 Mar 24
SC 13G/A
T. Rowe Price Investment Management, Inc.
16 Feb 24
SC 13G
Kynam Capital Management, LP
14 Feb 24
SC 13G
T. Rowe Price Investment Management, Inc.
14 Feb 24
SC 13G
T. Rowe Price Investment Management, Inc.
14 Feb 23
SC 13G/A
FMR LLC
8 Feb 21
SC 13G/A
BlackRock Inc.
9 Oct 20
SC 13G
Beneficial ownership report
7 Feb 20
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q3 2023
7.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 40 |
Opened positions | 9 |
Closed positions | 8 |
Increased positions | 17 |
Reduced positions | 11 |
13F shares | Current |
---|---|
Total value | 21.75 bn |
Total shares | 11.52 mm |
Total puts | 36.60 k |
Total calls | 6.10 k |
Total put/call ratio | 6.0 |
Largest owners | Shares | Value |
---|---|---|
T. Rowe Price Investment Management | 7.69 mm | $51.66 mm |
Logos Global Management | 950.00 k | $6.38 bn |
Hudson Bay Capital Management | 455.00 k | $3.06 bn |
Ghost Tree Capital | 400.00 k | $2.69 bn |
Knott David M Jr | 345.00 k | $2.32 mm |
ExodusPoint Capital Management | 255.56 k | $1.72 mm |
AlphaCentric Advisors | 185.00 k | $1.24 bn |
Point72 Asset Management | 174.82 k | $1.17 bn |
Marshall Wace | 162.67 k | $1.09 bn |
Optiver Holding B.V. | 144.04 k | $967.96 mm |